Chapter 14Strategic Resources & Consequences Report: Case No. 3—Pharmaceutics and Biotech
As in the preceding case study of insurance companies, practically everyone is a customer of drug or biotech companies. Few, though, are satisfied customers. Many complain about exorbitant drug prices, and the socially conscious question the justification for extended patent protection of essential drugs, particularly in Third World countries. If that's not ...
With Safari, you learn the way you learn best. Get unlimited access to videos, live online training,
learning paths, books, interactive tutorials, and more.